Beacon Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.73M | Buy |
10,847
+233
| +2% | +$50.1K | 0.25% | 95 |
|
|
2026
Q1 | $2.31M | Buy |
10,614
+3
| +0% | +$665 | 0.23% | 105 |
|
|
2025
Q4 | $2.42M | Buy |
10,611
+107
| +1% | +$24.4K | 0.24% | 98 |
|
|
2025
Q3 | $2.43M | Buy |
10,504
+127
| +1% | +$25.9K | 0.24% | 102 |
|
|
2025
Q2 | $1.93M | Buy |
10,377
+140
| +1% | +$26K | 0.2% | 115 |
|
|
2025
Q1 | $2.14M | Sell |
10,237
-756
| -7% | -$147K | 0.23% | 101 |
|
|
2024
Q4 | $1.95M | Sell |
10,993
-24
| -0.2% | -$4.41K | 0.21% | 108 |
|
|
2024
Q3 | $2.18M | Sell |
11,017
-268
| -2% | -$50K | 0.24% | 98 |
|
|
2024
Q2 | $1.94M | Buy |
11,285
+143
| +1% | +$23.7K | 0.22% | 112 |
|
|
2024
Q1 | $2.03M | Sell |
11,142
-272
| -2% | -$46.9K | 0.23% | 104 |
|
|
2023
Q4 | $1.77M | Buy |
11,414
+285
| +3% | +$41.5K | 0.22% | 111 |
|
|
2023
Q3 | $1.64M | Sell |
11,129
-261
| -2% | -$38.3K | 0.23% | 101 |
|
|
2023
Q2 | $1.52M | Sell |
11,390
-267
| -2% | -$39.2K | 0.21% | 107 |
|
|
2023
Q1 | $1.88M | Sell |
11,657
-1,965
| -14% | -$300K | 0.26% | 95 |
|
|
2022
Q4 | $2.2M | Sell |
13,622
-769
| -5% | -$118K | 0.3% | 88 |
|
|
2022
Q3 | $2.05M | Sell |
14,391
-660
| -4% | -$94.7K | 0.32% | 83 |
|
|
2022
Q2 | $2.29M | Sell |
15,051
-31
| -0.2% | -$4.74K | 0.34% | 84 |
|
|
2022
Q1 | $2.47M | Sell |
15,082
-21
| -0.1% | -$3.05K | 0.33% | 82 |
|
|
2021
Q4 | $2.04M | Buy |
15,103
+241
| +2% | +$28.5K | 0.27% | 88 |
|
|
2021
Q3 | $1.62M | Buy |
14,862
+393
| +3% | +$44.9K | 0.22% | 100 |
|
|
2021
Q2 | $1.68M | Buy |
14,469
+126
| +0.9% | +$14.2K | 0.24% | 99 |
|
|
2021
Q1 | $1.61M | Hold |
14,343
| – | – | 0.25% | 100 |
|
|
2020
Q4 | $1.61M | Sell |
14,343
-1,214
| -8% | -$117K | 0.25% | 101 |
|
|
2020
Q3 | $1.36M | Buy |
15,557
+447
| +3% | +$42.1K | 0.24% | 98 |
|
|
2020
Q2 | $1.46M | Buy |
15,110
+181
| +1% | +$15.9K | 0.28% | 94 |
|
|
2020
Q1 | $1.22M | Buy |
14,929
+5,253
| +54% | +$447K | 0.27% | 97 |
|
|
2019
Q4 | $857K | Sell |
9,676
-488
| -5% | -$40.5K | 0.11% | 124 |
|
|
2019
Q3 | $761K | Buy |
10,164
+149
| +1% | +$10.2K | 0.13% | 122 |
|
|
2019
Q2 | $728K | Buy |
10,015
+1,918
| +24% | +$151K | 0.12% | 125 |
|
|
2019
Q1 | $653 | Buy |
8,097
+638
| +9% | +$52.2K | 0.11% | 122 |
|
|
2018
Q4 | $680K | Buy |
7,459
+30
| +0.4% | +$2.64K | 0.13% | 116 |
|
|
2018
Q3 | $703K | Sell |
7,429
-1,222
| -14% | -$116K | 0.12% | 118 |
|
|
2018
Q2 | $802K | Buy |
8,651
+26
| +0.3% | +$2.54K | 0.14% | 113 |
|
|
2018
Q1 | $816K | Sell |
8,625
-870
| -9% | -$95.6K | 0.14% | 114 |
|
|
2017
Q4 | $918K | Sell |
9,495
-3,285
| -26% | -$310K | 0.16% | 99 |
|
|
2017
Q3 | $1.14M | Buy |
12,780
+253
| +2% | +$19.3K | 0.21% | 87 |
|
|
2017
Q2 | $908K | Sell |
12,527
-76
| -0.6% | -$5.11K | 0.17% | 92 |
|
|
2017
Q1 | $825K | Buy |
12,603
+3,816
| +43% | +$240K | 0.16% | 92 |
|
|
2016
Q4 | $550K | Buy |
8,787
+952
| +12% | +$58.1K | 0.11% | 113 |
|
|
2016
Q3 | $492K | Buy |
7,835
+611
| +8% | +$39.6K | 0.1% | 130 |
|
|
2016
Q2 | $447K | Sell |
7,224
-5,641
| -44% | -$344K | 0.1% | 124 |
|
|
2016
Q1 | $733K | Buy |
12,865
+1,856
| +17% | +$103K | 0.16% | 85 |
|
|
2015
Q4 | $658K | Buy |
11,009
+259
| +2% | +$14.9K | 0.15% | 89 |
|
|
2015
Q3 | $567K | Sell |
10,750
-5,568
| -34% | -$362K | 0.14% | 93 |
|
|
2015
Q2 | $1.1M | Buy |
16,318
+1,091
| +7% | +$71.2K | 0.24% | 71 |
|
|
2015
Q1 | $887K | Buy |
15,227
+2,817
| +23% | +$170K | 0.2% | 78 |
|
|
2014
Q4 | $822K | Buy |
12,410
+2,422
| +24% | +$153K | 0.17% | 88 |
|
|
2014
Q3 | $584K | Sell |
9,988
-1,806
| -15% | -$100K | 0.13% | 109 |
|
|
2014
Q2 | $670K | Buy |
11,794
+5,039
| +75% | +$264K | 0.15% | 96 |
|
|
2014
Q1 | $345K | Buy |
+6,755
| New | +$341K | 0.07% | 140 |
|
Other funds holding ABBV
ECSS
ATO
Beacon Financial Group's ABBV Position: Q2 2026 in Review
Beacon Financial Group increased its AbbVie (ABBV) stake by 2.2% in Q2 2026, buying an estimated $50.1K and bringing the position to 10,847 shares worth $2.73M. The position accounts for 0.25% of the portfolio, ranked #95.
Beacon Financial Group first reported a position in ABBV in Q1 2014 and has held it in 50 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Beacon Financial Group held 10,847 shares of AbbVie worth $2.73M as of Q2 2026.
- Beacon Financial Group bought 233 AbbVie shares in Q2 2026, an estimated $50.1K.
- AbbVie made up 0.25% of Beacon Financial Group's portfolio in Q2 2026, its #95 holding.
- Beacon Financial Group first reported a position in AbbVie in Q1 2014 and has held it in 50 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Beacon Financial Group's 13F filing for Q2 2026, filed 16 Jul 2026.